MEREO BIOPHARMA GROUP PLC (MREO) Capital expenditures 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$20,000FY2025 · since FY2022: $13,000 → $20,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20,000 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $13,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice